You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable renal cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oligometastatic Renal Cell Carcinoma Trial in Rome (Pembrolizumab injection plus metastasis directed treatment (surgery or RT),

Not yet recruiting
  • Oligometastatic Renal Cell Carcinoma
  • Pembrolizumab injection plus metastasis directed treatment (surgery or RT)
  • Tumor resection or RT
  • Rome, RM, Italy
    Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Oct 10, 2022

Renal Cell Carcinoma Trial in Albany, Houston, Quebec (HSPPC-96)

Terminated
Has Results
  • Renal Cell Carcinoma
  • HSPPC-96
  • Albany, New York
  • +2 more
May 10, 2021

Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)

Recruiting
  • Liver Metastases
  • +10 more
  • DNX-2440
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute, Inc.
Mar 28, 2022

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Penpulimab injection
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
Oct 7, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023

The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

Recruiting
  • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
  • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
  • Hanzhou, Zhejiang, China
    Lulu Liu
Jul 14, 2023

Cutaneous Squamous Cell Carcinoma Trial in Tampa (Pramlintide)

Suspended
  • Cutaneous Squamous Cell Carcinoma
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Oesophageal Squamous Cell Carcinoma Trial in Shanghai (PD-L1 Antibody SHR-1316)

Recruiting
  • Oesophageal Squamous Cell Carcinoma
  • PD-L1 Antibody SHR-1316
  • Shanghai, China
    180 Fenglin Road
Jun 12, 2022

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab plus TP, TP)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Camrelizumab plus TP
    • TP
    • Wuhan, Hubei, China
      Hospital of Stomatology, Wuhan University
    Mar 22, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Merkel Cell Carcinoma Trial in Milan (Retifanlimab, Cisplatin, Etoposide)

    Recruiting
    • Merkel Cell Carcinoma
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
    Jan 4, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Neoadjuvant Chemoimmunotherapy
    • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
    • (no location specified)
    Feb 14, 2023

    ctDNA Testing Plus AI-based Pathology in Resectable LSCC

    Recruiting
    • Lung Squamous Cell Carcinoma
    • WES and ctDNA detection
    • Changsha, Hunan, China
      Department of Thoracic Surgery, Second Xiangya Hospital of Centr
    Mar 18, 2023

    Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

    Not yet recruiting
    • Resectable Esophageal Squamous Cell Carcinoma
    • Neoadjuvant Therapy
    • (no location specified)
    Apr 18, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

    Available
    • Clear Cell Renal Cell Carcinoma
    • 89Zr-DFO-girentuximab
    • Los Angeles, California
      UCLA
    Oct 12, 2023

    Esophageal Squamous Cell Carcinoma Trial (Envafolimab, Albumin-Bound Paclitaxel, Carboplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Sep 21, 2022

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 28, 2023

    Pancreas Cancer, Lung Cancer, Renal Cancer Trial in Boston (MR-guided Linac)

    Recruiting
    • Pancreas Cancer
    • +12 more
    • MR-guided Linac
    • Boston, Massachusetts
    • +1 more
    Sep 21, 2021